Electroosmosis Dominates Electrophoresis of Antibiotic Transport Across the Outer Membrane Porin F.


Journal

Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626

Informations de publication

Date de publication:
02 06 2020
Historique:
received: 17 12 2019
revised: 12 03 2020
accepted: 09 04 2020
pubmed: 30 4 2020
medline: 15 5 2021
entrez: 30 4 2020
Statut: ppublish

Résumé

We report that the dynamics of antibiotic capture and transport across a voltage-biased OmpF nanopore is dominated by the electroosmotic flow rather than the electrophoretic force. By reconstituting an OmpF porin in an artificial lipid bilayer and applying an electric field across it, we are able to elucidate the permeation of molecules and their mechanism of transport. This field gives rise to an electrophoretic force acting directly on a charged substrate but also indirectly via coupling to all other mobile ions, causing an electroosmotic flow. The directionality and magnitude of this flow depends on the selectivity of the channel. Modifying the charge state of three different substrates (norfloxacin, ciprofloxacin, and enoxacin) by varying the pH between 6 and 9 while the charge and selectivity of OmpF is conserved allows us to work under conditions in which electroosmotic flow and electrophoretic forces add or oppose. This configuration allows us to identify and distinguish the contributions of the electroosmotic flow and the electrophoretic force on translocation. Statistical analysis of the resolvable dwell times reveals rich kinetic details regarding the direction and the stochastic movement of antibiotics inside the nanopore. We quantitatively describe the electroosmotic velocity component experienced by the substrates and their diffusion coefficients inside the porin with an estimate of the energy barrier experienced by the molecules caused by the interaction with the channel wall, which slows down the permeation by several orders of magnitude.

Identifiants

pubmed: 32348725
pii: S0006-3495(20)30330-1
doi: 10.1016/j.bpj.2020.04.011
pmc: PMC7264812
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Porins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2844-2852

Informations de copyright

Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Références

Nat Nanotechnol. 2013 Dec;8(12):946-51
pubmed: 24185943
Biophys J. 2010 Jul 7;99(1):134-43
pubmed: 20655841
J Chem Phys. 2010 May 21;132(19):195101
pubmed: 20499989
EMBO J. 2008 Aug 6;27(15):2171-80
pubmed: 18636093
Biofabrication. 2015 May 22;7(2):025007
pubmed: 26000798
Nano Lett. 2010 Jun 9;10(6):2162-7
pubmed: 20438117
FEBS Lett. 1997 Jul 14;411(2-3):201-5
pubmed: 9271205
Biophys J. 2003 Dec;85(6):3718-29
pubmed: 14645063
J Chem Phys. 2010 Jul 28;133(4):045101
pubmed: 20687689
ACS Nano. 2011 May 24;5(5):3628-38
pubmed: 21476590
J Chem Phys. 2007 Apr 28;126(16):164903
pubmed: 17477630
Angew Chem Int Ed Engl. 2019 Mar 26;58(14):4737-4741
pubmed: 30701680
ACS Nano. 2017 Jun 27;11(6):5465-5473
pubmed: 28485920
ACS Appl Mater Interfaces. 2016 May 25;8(20):13166-79
pubmed: 27159806
J Chromatogr A. 2005 Jan 28;1064(1):19-24
pubmed: 15729816
Proc Natl Acad Sci U S A. 1972 Dec;69(12):3561-6
pubmed: 4509315
Nat Rev Microbiol. 2008 Dec;6(12):893-903
pubmed: 18997824
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):281-305
pubmed: 11259844
Sci Transl Med. 2014 Mar 19;6(228):228ed7
pubmed: 24648337
J Chem Phys. 2010 Oct 28;133(16):165102
pubmed: 21033823
Eur Biophys J. 2009 Oct;38(8):1141-5
pubmed: 19506850
Phys Rev Lett. 1993 Apr 12;70(15):2352-2355
pubmed: 10053539
Biochim Biophys Acta. 2009 May;1794(5):808-16
pubmed: 19100346
FEMS Microbiol Lett. 1998 Jun 1;163(1):65-72
pubmed: 9631547
J Biol Chem. 1996 Aug 23;271(34):20669-75
pubmed: 8702816
Nat Commun. 2017 Oct 16;8(1):935
pubmed: 29038539
Microbiol Mol Biol Rev. 2003 Dec;67(4):593-656
pubmed: 14665678
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15498-503
pubmed: 14676320
Biophys J. 2006 Feb 15;90(4):1202-11
pubmed: 16299071
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19720-5
pubmed: 19060213
Biophys J. 2016 Feb 2;110(3):600-611
pubmed: 26840725
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):63-7
pubmed: 26036449
J Phys Chem B. 2010 Apr 22;114(15):5170-9
pubmed: 20349984
Biophys J. 2006 Dec 15;91(12):4392-400
pubmed: 16997866
J Phys Chem Lett. 2014 Dec 18;5(24):4362-7
pubmed: 26273988

Auteurs

Jayesh A Bafna (JA)

Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.

Sushil Pangeni (S)

Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.

Mathias Winterhalter (M)

Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.

M Alphan Aksoyoglu (MA)

Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany. Electronic address: m.aksoyoglu@jacobs-university.de.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH